BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 28394971)

  • 1. [Reply. Inappropriate use of sulfonylureas in older adults].
    Passi Á
    Rev Med Chil; 2016 Nov; 144(11):1497-1498. PubMed ID: 28394971
    [No Abstract]   [Full Text] [Related]  

  • 2. [Inappropriate use of sulfonylureas in older adults].
    Pacheco J
    Rev Med Chil; 2016 Nov; 144(11):1497. PubMed ID: 28394970
    [No Abstract]   [Full Text] [Related]  

  • 3. [Incidence of severe secondary effects during treatment with sulfonylureas and biguanides].
    Berger W
    Journ Annu Diabetol Hotel Dieu; 1986; ():243-53. PubMed ID: 3613372
    [No Abstract]   [Full Text] [Related]  

  • 4. Race, ethnicity, and use of thiazolidinediones among US adults with diabetes.
    Aquilante CL; Zhang W; McCollum M
    Curr Med Res Opin; 2007 Mar; 23(3):489-94. PubMed ID: 17355730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary failure to sulfonylureas in NIDDM. Are sulfonylureas still useful?
    Menon KN; Seshadri MS
    J Assoc Physicians India; 1990 Aug; 38(8):533-4. PubMed ID: 2123182
    [No Abstract]   [Full Text] [Related]  

  • 6. Sulfonylureas.
    Kalra S; Gupta Y
    J Pak Med Assoc; 2015 Jan; 65(1):101-4. PubMed ID: 25831689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Polymorphism of the sulfonylurea receptor gene in type 2 diabetes mellitus].
    Owecki M; Horst-Sikorska W; Kaczmarek M; Słomski R; Sowiński J
    Pol Arch Med Wewn; 2003 Feb; 109(2):143-8. PubMed ID: 12879777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulfonylureas and risk of falls and fractures among nursing home residents with type 2 diabetes mellitus.
    Lapane KL; Jesdale BM; Dubé CE; Pimentel CB; Rajpathak SN
    Diabetes Res Clin Pract; 2015 Aug; 109(2):411-9. PubMed ID: 26008723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence of CYP2C9*3 allele increases risk for hypoglycemia in Type 2 diabetic patients treated with sulfonylureas.
    Ragia G; Petridis I; Tavridou A; Christakidis D; Manolopoulos VG
    Pharmacogenomics; 2009 Nov; 10(11):1781-7. PubMed ID: 19891554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [40 years of using sulfonylurea derivatives for treatment of diabetes].
    Sieradzki J
    Przegl Lek; 1996; 53(9):641-6. PubMed ID: 8992529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sulfonylureas].
    Kobayashi K; Shimano H
    Nihon Rinsho; 2012 May; 70 Suppl 3():602-7. PubMed ID: 22768585
    [No Abstract]   [Full Text] [Related]  

  • 12. Failure of sulfonylureas in type 2 diabetes.
    Yildiz BO; Gürlek A
    Horm Metab Res; 1999 Apr; 31(4):293-4. PubMed ID: 10333089
    [No Abstract]   [Full Text] [Related]  

  • 13. The risk of overall mortality in patients with type 2 diabetes receiving glipizide, glyburide, or glimepiride monotherapy: a retrospective analysis.
    Pantalone KM; Kattan MW; Yu C; Wells BJ; Arrigain S; Jain A; Atreja A; Zimmerman RS
    Diabetes Care; 2010 Jun; 33(6):1224-9. PubMed ID: 20215447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. If not sulfonylureas, then what?
    Leibovitch ER
    Geriatrics; 2004 Sep; 59(9):47-8. PubMed ID: 15461239
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of sulfonylureas with insulin in type 2 diabetes mellitus.
    Kabadi MU; Kabadi UM
    Ann Pharmacother; 2003 Nov; 37(11):1572-6. PubMed ID: 14565810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combination therapy with sulfonylurea plus insulin in "secondary failure" of type 2 diabetes].
    Lotz N
    Ther Umsch; 1990 Jan; 47(1):49-54. PubMed ID: 2408182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible risk of sulfonylureas in the treatment of non-insulin-dependent diabetes mellitus and coronary artery disease.
    Mühlhauser I; Sawicki PT; Berger M
    Diabetologia; 1997 Dec; 40(12):1492-3. PubMed ID: 9447960
    [No Abstract]   [Full Text] [Related]  

  • 18. Oral combination therapy with thiazolidinediones and sulfonylureas in type 2 diabetes.
    Charbonnel B
    Int J Clin Pract Suppl; 2007 Jun; (153):1-2. PubMed ID: 17594387
    [No Abstract]   [Full Text] [Related]  

  • 19. Progressing From Metformin to Sulfonylureas or Meglitinides.
    Grant JS; Graven LJ
    Workplace Health Saf; 2016 Sep; 64(9):433-9. PubMed ID: 27621259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical use of oral sulfonylureas in the management of non-insulin dependent diabetes mellitus (NIDDM).
    Ponte CD
    W V Med J; 1990 Oct; 86(10):455-8. PubMed ID: 2238629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.